Your browser doesn't support javascript.
loading
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.
Liu, Mark C; Chipps, Bradley; Munoz, Xavier; Devouassoux, Gilles; Bergna, Miguel; Smith, Steven G; Price, Robert G; Galkin, Dmitry V; Azmi, Jay; Mouneimne, Dalal; Albers, Frank C; Chapman, Kenneth R.
Afiliación
  • Liu MC; Divisions of Allergy and Clinical Immunology, Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA.
  • Chipps B; Capital Allergy and Respiratory Disease Center, Sacramento, CA, USA.
  • Munoz X; Pulmonology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Devouassoux G; Ciber Enfermedades Respiratorias, Madrid, Spain.
  • Bergna M; Service de Pneumologie, Hôpital de la Croix Rousse, Hospices Civils de Lyon, UCB Lyon, Lyon, France.
  • Smith SG; Respiratory Research, CEMER, Vicente Lopez, Buenos Aires, Argentina.
  • Price RG; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
  • Galkin DV; Biostatistics, GSK, Stevenage, Hertfordshire, UK.
  • Azmi J; Global Respiratory Medical Franchise, GSK, Research Triangle Park, NC, USA.
  • Mouneimne D; Chiesi USA, Cary, NC, USA.
  • Albers FC; Respiratory TAU, GSK, Uxbridge, Middlesex, UK.
  • Chapman KR; Global Medical Affairs, GSK House, Brentford, Middlesex, UK.
Respir Res ; 22(1): 144, 2021 May 10.
Article en En | MEDLINE | ID: mdl-33971856
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos / Sustitución de Medicamentos / Anticuerpos Monoclonales Humanizados / Omalizumab / Pulmón Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Res Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos / Sustitución de Medicamentos / Anticuerpos Monoclonales Humanizados / Omalizumab / Pulmón Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Respir Res Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos